The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in ...

Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.

Two new drugs will soon be available to target little-known forms of high cholesterol, which are driven by our genes and ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

Regulating Cholesterol Levels Might Be the Key to Improving Cancer Treatment Apr. 30 ... reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol ...

Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans ...